Publications

• Racial and Socioeconomic Disparities in Cutaneous T-Cell Lymphoma Survival: Insights From the National Cancer Database.
  Clin Lymphoma Myeloma Leuk
  05/07/2025 Authors: Allen P; Li Y; Hamid M; Zhi J
• Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.
  J Clin Oncol Volume: 43 Page(s): 1198 - 1209
  04/01/2025 Authors: Foss FM; Kim YH; Prince HM; Akilov OE; Querfeld C; Seminario-Vidal L; Fisher DC; Kuzel TM; Yannakou CK; Geskin LJ
• Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL).
  Curr Hematol Malig Rep Volume: 20 Page(s): 5
  01/13/2025 Authors: Case KB; Allen PB
• The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.
  Blood Adv Volume: 8 Page(s): 3507 - 3518
  07/09/2024 Authors: Bhansali RS; Ellin F; Relander T; Cao M; Li W; Long Q; Ganesan N; Stuver R; Horwitz SM; Wudhikarn K
• Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.
  Blood Adv Volume: 8 Page(s): 2327 - 2331
  05/28/2024 Authors: Melody M; Epperla N; Shouse G; Romancik J; Allen P; Moyo TK; Kenkre V; Ollila T; Fitzgerald L; Hess B
• Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.
  Blood Adv Volume: 7 Page(s): 7485 - 7493
  12/26/2023 Authors: Steiner RE; Hwang SR; Khurana A; Habermann TM; Epperla N; Annunzio K; Allen PB; Baird K; Paulino D; Alderuccio JP
• Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
  CNS Oncol Volume: 12 Page(s): CNS105
  12/01/2023 Authors: Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB
• Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.
  Blood Adv Volume: 7 Page(s): 2670 - 2676
  06/27/2023 Authors: Allen PB; Lu X; Chen Q; O'Shea K; Chmiel JS; Slonim LB; Sukhanova M; Savas H; Evens AM; Advani R
• Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
  Blood Adv Volume: 7 Page(s): 2459 - 2462
  06/13/2023 Authors: Chang A; Koff JL; Lai L; Orellana-Noia VM; Surati M; Leal AMK; Ellis ML; Wali B; Moreno A; Linderman SL
• Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia.
  Leuk Lymphoma Volume: 64 Page(s): 597 - 604
  03/01/2023 Authors: Allen PB; Goyal S; Switchenko J; Tarabadkar E; Pouch S; Parikh P; Palmer A; Martini D; Kim E; Lechowicz MJ
• Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
  Cancer Volume: 129 Page(s): 541 - 550
  02/15/2023 Authors: Allen PB; McCook-Veal AA; Switchenko JM; Paulino DM; Niyogusaba T; Baird KM; Tarabadkar ES; Lechowicz MJ
• Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.
  Cancer Res Commun Volume: 2 Page(s): 1684 - 1692
  12/01/2022 Authors: Chang A; Akhtar A; Lai L; Orellana-Noia VM; Linderman SL; McCook-Veal AA; Switchenko JM; Saini M; Valanparambil RM; Blum KA
• Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial.
  Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): e1084 - e1091
  12/01/2022 Authors: Romancik JT; Chen Z; Allen PB; Waller EK; Valla K; Colbert A; Rosand C; Palmer AF; Flowers CR; Cohen JB
• Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Szary Syndrome.
  JAMA Dermatol Volume: 158 Page(s): 1293 - 1299
  11/01/2022 Authors: Allen PB; Goyal S; Niyogusaba T; O'Leary C; Ayers A; Tarabadkar ES; Khan MK; Lechowicz MJ
• CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.
  Clin Lymphoma Myeloma Leuk Volume: 22 Suppl 2 Page(s): S281 - S282
  10/01/2022 Authors: Chang A; Lai L; Akhtar A; Linderman S; Orellana-Noia V; Saini M; Valanparambil R; Blum K; Allen P; Lechowicz M
• Baseline radiographic imaging is useful in identifying risk factors for survival and lymph node progression
  Volume: 173 Page(s): S13 - S14
  09/01/2022 Authors: Allen PB; Baird K; Paulino D; Kives M; Aker TH; Abousand A; Leal A; O'Leary C; Palmer A; Parikh P
• African American and Caucasian patients with Szary syndrome have no differences in outcomes at an ethnically diverse urban medical center.
  Leuk Lymphoma Volume: 63 Page(s): 2094 - 2101
  09/01/2022 Authors: Martini DJ; Goyal S; Switchenko JM; Lechowicz MJ; Allen PB
• Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
  Clin Lymphoma Myeloma Leuk Volume: 22 Page(s): e435 - e442
  07/01/2022 Authors: Hamid MS; Rutherford SC; Jang H; Kim S; Patel K; Bartlett NL; Malecek M-K; Watkins MP; Maddocks KJ; Bond DA
• What is the role of chest X-ray imaging in the acute management of children with sickle cell disease?
  Br J Haematol Volume: 196 Page(s): 402 - 413
  01/01/2022 Authors: Griffin R; Panayiotou A; Allen P; Height S; Chakravorty S; Rees DC
• Racial differences in clinical presentation and outcomes in mycosis fungoides and Szary syndrome in the United States: a large singe center retrospective analysis.
  Eur J Cancer Volume: 156 Suppl 1 Page(s): S34
  10/01/2021 Authors: Allen PB; Goyal S; O'Leary C; Ayers A; Niyogusaba T; Khan MK; Lechowicz MJ
• Prolonged Cytopenias in Autologous Stem Cell Transplantation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  Volume: 21 Page(s): S396 - S397
  09/01/2021 Authors: Santapuram P; Rupji M; Graiser M; Waller E; Blum K; Allen P; Koff J; Heffner L; Lechowicz M; Lonial S
• T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma.
  JAMA Dermatol Volume: 157 Page(s): 954 - 962
  08/01/2021 Authors: Marks JA; Switchenko JM; Martini DJ; Tarabadkar ES; Khan MK; Lechowicz MJ; Allen PB
• Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.
  Blood Volume: 137 Page(s): 1318 - 1326
  03/11/2021 Authors: Allen PB; Savas H; Evens AM; Advani RH; Palmer B; Pro B; Karmali R; Mou E; Bearden J; Dillehay G
• Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.
  Oncology (Williston Park) Volume: 34 Page(s): 494 - 499
  11/12/2020 Authors: Payne JB; Flowers CR; Allen PB
• Ixazomib with or without Rituximab Following Immunochemotherapy and Autologous Stem Cell Transplant in Mantle Cell Lymphoma
  Volume: 136
  11/05/2020 Authors: Romancik JT; Allen PB; Waller EK; Chen Z; Valla K; Dixon K; Reagan DJ; Colbert AB; Rosand C; Palmer A
• Evaluating Outcomes for Autologous Hematopoietic Cell Transplantation for Diffuse Large B-Cell Lymphoma in the CAR-T Era
  Volume: 136
  11/05/2020 Authors: Santapuram PR; Rupji M; Graiser M; Waller EK; Blum KA; Allen PB; Koff JL; Heffner L; Lechowicz MJ; Lonial S
• Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL).
  Leuk Lymphoma Volume: 61 Page(s): 2652 - 2658
  11/01/2020 Authors: Allen PB; Switchenko J; Ayers A; Kim E; Lechowicz MJ
• Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet Therapy.
  Clin Lymphoma Myeloma Leuk Volume: 20 Page(s): 757 - 767.e3
  11/01/2020 Authors: Kudelka MR; Switchenko JM; Lechowicz MJ; Esiashvili N; Flowers CR; Khan MK; Allen PB
• Hepatosplenic T-cell lymphoma: a rare but challenging entity.
  Blood Volume: 136 Page(s): 2018 - 2026
  10/29/2020 Authors: Pro B; Allen P; Behdad A
• Incidence of Cutaneous T Cell Lymphoma and Air Levels of Benzene and Trichloroethylene
  Volume: 95 Page(s): S13 - S13
  10/01/2020 Authors: Gandrakota N; Lechowicz M; Allen P; Ward K; Switchenko J
• Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
  Curr Oncol Rep Volume: 22 Page(s): 114
  08/22/2020 Authors: Allen P
• A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.
  Leuk Lymphoma Volume: 61 Page(s): 1555 - 1564
  07/01/2020 Authors: Allen PB; Ayers A; Behera M; Evens AM; Flowers C
• Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes.
  Curr Oncol Rep Volume: 22 Page(s): 44
  04/16/2020 Authors: Allen PB; Pro B
• Clustering of cutaneous T-cell lymphoma is associated with increased levels of the environmental toxins benzene and trichloroethylene in the state of Georgia.
  Cancer Volume: 126 Page(s): 1700 - 1707
  04/15/2020 Authors: Clough L; Bayakly AR; Ward KC; Khan MK; Chen SC; Lechowicz MJ; Flowers CR; Allen PB; Switchenko JM
• Evidence-Based Minireview: What is the optimal timing of anti-PD-1 antibodies in relapsed classical Hodgkin lymphoma?
  Hematology Am Soc Hematol Educ Program Volume: 2019 Page(s): 249 - 251
  12/06/2019 Authors: Allen PB; LaCasce AS
• Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Multicenter Phase 2 PET-Adapted Study of Sequential PEM and AVD
  Volume: 134
  11/13/2019 Authors: Allen P; Savas H; Evens AM; Pro B; Karmali R; Palmer BA; Mou E; Bearden J; Scholtens DM; Dillehay G
• North American Practice Patterns for PET-2 Positive Hodgkin Lymphoma
  Volume: 134
  11/13/2019 Authors: Hamid MS; Rutherford SC; Kim S; Bartlett NL; Malecek M-K; Watkins M; Maddocks KJ; Bond DA; Feldman TA; Magarelli G
• Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment
  Volume: 134
  11/13/2019 Authors: Bryan LJ; Smith SE; Allen P; Casulo C; Palmer BA; Karmali R; Pro B; Scholtens DM; Savas H; Mehta J
• Mortality and Risk Factors for Bacteremia in Patients with Cutaneous T-Cell Lymphoma (CTCL) at Emory University
  Volume: 134
  11/13/2019 Authors: Allen P; Kim E; Ayers A; Lechowicz MJ
• Management of NK/T-Cell Lymphoma, Nasal Type.
  J Oncol Pract Volume: 15 Page(s): 513 - 520
  10/01/2019 Authors: Allen PB; Lechowicz MJ
• Association of geographic clustering of cutaneous T-cell lymphoma in the state of Georgia with environmental exposure to benzene and trichloroethylene
  Volume: 37
  05/20/2019 Authors: Allen PB; Clough L; Bayakly AR; Ward KC; Khan MK; Chen S; Flowers C; Switchenko JM
• Influenza Vaccination Documentation Rates During the First Year After Diagnosis of Diffuse Large B Cell Lymphoma.
  Clin Lymphoma Myeloma Leuk Volume: 19 Page(s): 239 - 243
  04/01/2019 Authors: Chang A; Payne JB; Allen PB; Koff JL; Ahmed R; Flowers CR; Bednarczyk RA
• Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma.
  Curr Oncol Rep Volume: 21 Page(s): 39
  03/27/2019 Authors: Allen PB; Winter JN
• Moving Toward Targeted Therapy in the Treatment of Angioimmunoblastic T-Cell Lymphoma.
  J Oncol Pract Volume: 15 Page(s): 145 - 146
  03/01/2019 Authors: Allen PB
• A Phase II Study(A)over-cap of Sequential Pembrolizumab (PEM)(A)over-cap Followed(A)over-cap By AVD for Frontline Treatment(A)over-cap of Classical Hodgkin Lymphoma (CHL): Quantifying Response Following(A)over-cap PEM Monotherapy(A)over-cap with FDG-PLT-Derived Metabolic Tumor Volume and Total Lesion Glycolysis
  Volume: 132
  11/29/2018 Authors: Savas H; Allen P; Evens AM; Pro B; Dillehay G; Rademaker A; Palmer BA; Advani R; Gordon LI; Winter JN
• Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy
  Volume: 132
  11/29/2018 Authors: Kudelka M; Lechowicz MJ; Khan MK; Esiashvili N; Flowers CR; Allen P
• Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm.
  Am J Dermatopathol Volume: 40 Page(s): 610 - 613
  08/01/2018 Authors: Behdad A; Allen P; Lu X; Zhou XA; Guitart J; Chen Q; Pro B
• Association of insurance status and race with overall survival among patients with cutaneous T-cell lymphoma: A National Cancer DataBase analysis.
  Volume: 36
  05/20/2018 Authors: Allen PB; Flowers C; Lechowicz MJ; Goldstein J
• Impact of individual comorbidities on post-transplant outcomes for elderly patients with non-Hodgkin lymphoma (NHL).
  Volume: 36
  05/20/2018 Authors: Ip A; Switchenko JM; Graiser M; Koff JL; Gupta VA; Lechowicz MJ; Nooka AK; Kaufman JL; Lonial S; Waller EK
• Balancing patient value and payer cost in hematologic malignancies: can it be done?
  Expert Rev Pharmacoecon Outcomes Res Volume: 18 Page(s): 123 - 126
  04/01/2018 Authors: Allen PB; Flowers CR
• The impact of fertility preservation on treatment delay and progression-free survival in women with lymphoma: a single-centre experience.
  Br J Haematol Volume: 180 Page(s): 901 - 904
  03/01/2018 Authors: Allen PB; Pavone ME; Smith KN; Kazer RR; Rademaker A; Lawson AK; Moravek MB; Confino R; Gordon LI; Winter JN
• Hematologic toxicity is rare in relapsed patients treated with belinostat: a systematic review of belinostat toxicity and safety in peripheral T-cell lymphomas.
  Cancer Manag Res Volume: 10 Page(s): 6731 - 6742
  01/01/2018 Authors: Allen PB; Lechowicz MJ
• Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome.
  Expert Opin Investig Drugs Volume: 27 Page(s): 55 - 70
  01/01/2018 Authors: Chang A; Schlafer D; Flowers CR; Allen PB
• Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.
  Clin Med Insights Oncol Volume: 11 Page(s): 1179554917731072
  01/01/2017 Authors: Allen PB; Gordon LI
• PD-1 blockade in Hodgkin's lymphoma: learning new tricks from an old teacher.
  Expert Rev Hematol Volume: 9 Page(s): 939 - 949
  10/01/2016 Authors: Allen PB; Gordon LI
• Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
  J Clin Oncol Volume: 31 Page(s): e98 - 100
  03/01/2013 Authors: Allen PB; Koka R; Kleinberg ME; Baer MR
• EC145: a novel targeted agent for adenocarcinoma of the lung.
  Expert Opin Investig Drugs Volume: 21 Page(s): 755 - 761
  05/01/2012 Authors: Pribble P; Edelman MJ